StonvexLoading…
StonvexCore line items from TBTC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $3.91M | $11.05M | $8.01M | $5.87M |
Operating Income | $1.16M | $1.60M | $951.51K | $999.04K |
Net Income | $971.49K | $1.63M | $985.37K | $144.78K |
EPS (Diluted) | $0.21 | $0.35 | $0.21 | $0.20 |
Total Assets | $14.90M | $14.37M | $13.64M | $13.65M |
Total Liabilities | $1.62M | $1.52M | $1.39M | $1.40M |
Cash & Equivalents | $8.12M | $8.24M | $6.11M | $5.85M |
Free Cash Flow OCF − CapEx | Not available | $1.78M | $1.55M | $1.21M |
Shares Outstanding | 4.64M | 4.64M | 4.64M | 4.64M |